Researchers are excited about the medication , a innovative dual agonist showing significant data in initial trials for weight reduction . It works by targeting both pathways : GLP-1 and GIP, that , https://emiliavlhc915412.like-blogs.com/40624678/this-new-prospect-for-weight-loss